$ARX

ONeill Francis James sold $3.1M of ARX (indirect holdings)

ONeill Francis James (Co-Founder, Chief U/W Officer) sold 215,114 indirectly-held shares of Accelerant Holdings (ARX) at an average of $14.60 ($14.56–$14.63, $3.14M total) across 2 trades over 2026-07-27 to 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ONeill Francis James
Published Jul 29, 2026, 10:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARX
Neutral
medium confidence
Mentioned
$ARX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale size ($3.14M) and the fact it was executed across two open-market trades at $14.5580 to $14.6308 per share.

02

Market read

Traders may monitor ARX for any follow-on insider activity, but the filing alone does not introduce new fundamentals.

03

What to watch

Indirect holdings and pre-arranged timing can mask the true motivation; without context on total compensation, tax events, or prior sale cadence, signal quality is limited.

Relevance 5/10Novelty 3/10Timing: after-hours, filed 2026-07-29 for trades dated 2026-07-27 to 2026-07-28

Background

The article is an SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX) by ONeill Francis James, listed as co-founder and Chief U/W Officer, with an explicit 10b5-1 plan.

Company-level read

Ticker impact

$ARXNeutralMedium confidence
Context

SEC Form 4 shows co-founder sold 215,114 shares of ARX in open-market trades for about $3.14M under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary-source insider transaction with defined trade dates and a stated 10b5-1 plan, reducing the likelihood of an information leak. The article provides no accompanying operational or financial catalyst.

Market effects

No sector read-through; this is company-specific insider liquidity activity.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or tax-related execution under a 10b5-1 plan, so it may not reflect bearish fundamentals.

Key entities

  • Accelerant Holdings

    Subject of the Form 4 insider transaction disclosure.

  • ONeill Francis James

    Co-founder and Chief U/W Officer who sold ARX shares via a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARXHighAI 9/10

Why Is Accelerant Going Private Just One Year After Its IPO?

Accelerant Holdings (ARX) agreed to be acquired by Thoma Bravo in an all-cash deal valuing it at over $4 billion, about a year after its July 2025 IPO. ARX shares rose nearly 44% on Aug. 13, 2026. Class A and B holders receive $20.25 per share. Q2 2026 revenue was $356.9 million (+62.9% YoY) and net income $80 million.

$ARXHighAI 9/10

Accelerant Holdings (ARX) Soars 57% as Buyer Bets Big on Firm

Accelerant Holdings (NYSE:ARX) shares rose about 57% after Thoma Bravo agreed to acquire the company for $4 billion. The offer price is $20.25 per share, a 49% premium to the prior close. ARX said shareholders may receive a 6% annual ticking fee if regulatory approvals delay closing, expected in H1.

$ARXHighAI 9/10

Accelerant Holdings Agrees to Thoma Bravo Take-Private Merger

Accelerant Holdings (ARX) agreed to a take-private merger with Cherry Tree BidCo, affiliated with Thoma Bravo’s Discover Fund V. If completed, ARX shareholders will receive $20.25 per share plus a ticking amount, and ARX will be delisted. The deal needs two-thirds approval and regulatory clearances, with ACP holding about 82% voting rights to support it.